Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Leucovorin × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 76 Stomach Neoplasms 31 Pancreatic Neoplasms 26 Colonic Neoplasms 25 Rectal Neoplasms 22 Neoplasms 20 Neoplasm Metastasis 18 Esophageal Neoplasms 14 Cholangiocarcinoma 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Carcinoma, Non-Small-Cell Lung 11 Burkitt Lymphoma 11 Biliary Tract Neoplasms 11 Adenocarcinoma Of Esophagus 11 Adenocarcinoma 9 Ovarian Neoplasms 6 Gastrointestinal Neoplasms 6 Advanced Solid Tumors 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Lung Neoplasms 4 Leukemia, Biphenotypic, Acute 4 Leukemia 4 Gallbladder Neoplasms 4 Endometrial Neoplasms 4 Carcinoma, Renal Cell 4 Appendiceal Neoplasms 4 Urinary Bladder Neoplasms 3 Triple Negative Breast Neoplasms 3 Myelodysplastic Syndromes 3

Interventions

fludarabine 4 Cisplatin 4 Pemetrexed 3 Cyclophosphamide 3 pralsetinib 2 pembrolizumab 2 fludarabine phosphate 2 durvalumab 2 cobimetinib 2 atezolizumab 2 Whole-Body Irradiation 2 Vemurafenib 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Paclitaxel 2 Nivolumab 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Busulfan 2 130-nm albumin-bound paclitaxel 2 trametinib 1 spartalizumab 1 ruxolitinib 1 repotrectinib 1 ponatinib 1 pertuzumab 1 gilteritinib 1 enzalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡